Related Experiment Video
Updated: Jul 13, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
18.9K
Medically responsive amyloidogenic giant sellar-parasellar prolactinoma
Anoop Kumar Singh1, Shilpi2, Gayatri Kumari3
1Department of Neurosurgery, Lifeline Hospital and Research Center, Azamgarh, Uttar Pradesh, India.
Surgical Neurology International
|May 14, 2024
Summary
Giant amyloidogenic prolactinomas, a rare variant, are surprisingly responsive to medical therapy, challenging traditional surgical recommendations. Further research is needed to confirm optimal management strategies for these rare tumors.
Area of Science:
- Endocrinology
- Neurosurgery
- Pathology
Background:
- Giant prolactinomas are rare pituitary tumors, with the amyloidogenic subtype being exceptionally uncommon, characterized by extensive amyloid deposits.
- Historically, surgical management was recommended for amyloidogenic giant prolactinomas, diverging from the standard medical treatment for typical prolactinomas.
Observation:
- A case of a 32-year-old male with a giant amyloidogenic prolactinoma is presented.
- This patient exhibited unusual clinical, radiological, and pathological features.
- The tumor demonstrated a positive response to dopamine agonist therapy.
Findings:
- Amyloidogenic giant prolactinomas, despite their rarity and unique pathological features, exhibit medical responsiveness.
- The patient's tumor responded to dopamine agonist therapy, similar to conventional prolactinomas.
Implications:
- This case suggests that medical management, specifically with dopamine agonists, may be a viable option for amyloidogenic giant prolactinomas.
- Further clinical studies are warranted to establish definitive treatment guidelines for this rare condition, potentially shifting management paradigms.
Related Concept Videos
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...